Why Kymera Therapeutics Stock Popped This Week: Key Moves
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Compare total market funds to determine which has the lowest fees, balancing expense ratios with diversification and performance history.
28,601 articlesA flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Bitcoin surged toward a crucial resistance level as news spread that trump just flew china and a tech-heavy delegatio...
June payrolls rose just 57,000, signaling softer momentum. Yet three AI-driven stocks offer durable upside as corpora...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Ford shares jumped roughly 7% as Q1 momentum and Ford Pro strength lifted the full-year EBIT outlook, putting Ford ah...
AscendEX has suspended all operations as of July 1, 2026, warning users that full balance recovery cannot be guarante...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...
Oil trades around $79 per barrel as markets digest supply discipline and demand signals. The current price july 2026 ...
Bitcoin reserves on centralized venues remain a sizable market feature even after FTX. Analysts say liquidity, lendin...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
Nvidia could be headed toward a $300 stock price as AI demand, margins, and strategic bets align. This article breaks...